share_log

Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Maintains $1135 Price Target

Truist Securities Maintains Buy on Regeneron Pharmaceuticals, Maintains $1135 Price Target

Truist Securities維持對再生元製藥的買入,維持1135美元的目標股價
Moomoo 24/7 ·  03/26 09:35

Truist Securities analyst Robyn Karnauskas maintains Regeneron Pharmaceuticals (NASDAQ:REGN) with a Buy and maintains $1135 price target.

Truist Securities分析師羅賓·卡瑙斯卡斯維持Regeneron Pharmicals(納斯達克股票代碼:REGN)的買入並維持1135美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論